

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.10987440 |
| 2 | mannose metabolic process (GO:0006013) | 4.37343429 |
| 3 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.13651789 |
| 4 | response to muramyl dipeptide (GO:0032495) | 4.09654241 |
| 5 | response to peptidoglycan (GO:0032494) | 4.07637060 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.07587587 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.07587587 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.07587587 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.07587587 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.07587587 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.07587587 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.96620137 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.87306365 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.77455629 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.74614961 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.72895858 |
| 17 | histone H3-K4 trimethylation (GO:0080182) | 3.68915077 |
| 18 | detection of bacterium (GO:0016045) | 3.67791529 |
| 19 | detection of other organism (GO:0098543) | 3.65166935 |
| 20 | pre-miRNA processing (GO:0031054) | 3.63085487 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.59734243 |
| 22 | negative regulation of cell killing (GO:0031342) | 3.59734243 |
| 23 | histone H3-K4 methylation (GO:0051568) | 3.55459130 |
| 24 | synaptic vesicle maturation (GO:0016188) | 3.52198955 |
| 25 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.51487010 |
| 26 | histone H3-K36 demethylation (GO:0070544) | 3.46056729 |
| 27 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.41989137 |
| 28 | histone H4-K12 acetylation (GO:0043983) | 3.39296307 |
| 29 | locomotory exploration behavior (GO:0035641) | 3.29989217 |
| 30 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.29960031 |
| 31 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.25301139 |
| 32 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.17540680 |
| 33 | leukocyte aggregation (GO:0070486) | 3.17123427 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.12727873 |
| 35 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.10646020 |
| 36 | regulation of mast cell degranulation (GO:0043304) | 3.09371313 |
| 37 | germinal center formation (GO:0002467) | 3.08966658 |
| 38 | neutrophil activation involved in immune response (GO:0002283) | 3.08757083 |
| 39 | synaptic vesicle endocytosis (GO:0048488) | 3.08646164 |
| 40 | histone H4-K8 acetylation (GO:0043982) | 3.08046581 |
| 41 | histone H4-K5 acetylation (GO:0043981) | 3.08046581 |
| 42 | modulation by symbiont of host cellular process (GO:0044068) | 3.07400086 |
| 43 | histone H4 deacetylation (GO:0070933) | 3.06838365 |
| 44 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.04677815 |
| 45 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.02804678 |
| 46 | regulation of leukocyte degranulation (GO:0043300) | 3.01056249 |
| 47 | immunoglobulin mediated immune response (GO:0016064) | 3.00919577 |
| 48 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.99280955 |
| 49 | positive regulation of B cell differentiation (GO:0045579) | 2.98619107 |
| 50 | cellular response to virus (GO:0098586) | 2.97865905 |
| 51 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.97783409 |
| 52 | histone H4-K16 acetylation (GO:0043984) | 2.97703839 |
| 53 | GDP-mannose metabolic process (GO:0019673) | 2.95486622 |
| 54 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.95369380 |
| 55 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.91788349 |
| 56 | negative regulation of interleukin-12 production (GO:0032695) | 2.89777132 |
| 57 | detection of molecule of bacterial origin (GO:0032490) | 2.85973440 |
| 58 | negative regulation of T cell mediated immunity (GO:0002710) | 2.85857864 |
| 59 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.85282397 |
| 60 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.85165803 |
| 61 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.84071775 |
| 62 | negative regulation of granulocyte differentiation (GO:0030853) | 2.83612373 |
| 63 | negative regulation of histone methylation (GO:0031061) | 2.82587071 |
| 64 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.81862292 |
| 65 | adenosine receptor signaling pathway (GO:0001973) | 2.81855734 |
| 66 | synaptic vesicle exocytosis (GO:0016079) | 2.81813772 |
| 67 | regulation of B cell differentiation (GO:0045577) | 2.79818387 |
| 68 | regulation of histone H3-K27 methylation (GO:0061085) | 2.78874680 |
| 69 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.78413634 |
| 70 | response to host (GO:0075136) | 2.77910608 |
| 71 | response to host defenses (GO:0052200) | 2.77910608 |
| 72 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.77910608 |
| 73 | response to host immune response (GO:0052572) | 2.77544538 |
| 74 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.77544538 |
| 75 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.76242287 |
| 76 | positive regulation of interferon-alpha production (GO:0032727) | 2.75925192 |
| 77 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.75719965 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 2.75653479 |
| 79 | regulation of ARF protein signal transduction (GO:0032012) | 2.75027508 |
| 80 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.74694728 |
| 81 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.74694728 |
| 82 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.74694728 |
| 83 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.74507829 |
| 84 | megakaryocyte development (GO:0035855) | 2.73464550 |
| 85 | negative thymic T cell selection (GO:0045060) | 2.73112572 |
| 86 | response to type I interferon (GO:0034340) | 2.72920017 |
| 87 | cellular extravasation (GO:0045123) | 2.72121659 |
| 88 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.71451921 |
| 89 | detection of biotic stimulus (GO:0009595) | 2.70991047 |
| 90 | tolerance induction (GO:0002507) | 2.69615495 |
| 91 | negative T cell selection (GO:0043383) | 2.69123119 |
| 92 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.68916511 |
| 93 | negative regulation of innate immune response (GO:0045824) | 2.68429996 |
| 94 | cellular response to type I interferon (GO:0071357) | 2.68172375 |
| 95 | type I interferon signaling pathway (GO:0060337) | 2.68172375 |
| 96 | response to interleukin-15 (GO:0070672) | 2.68009976 |
| 97 | T cell migration (GO:0072678) | 2.67726144 |
| 98 | embryonic process involved in female pregnancy (GO:0060136) | 2.67395194 |
| 99 | histone lysine methylation (GO:0034968) | 2.65901265 |
| 100 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.65571981 |
| 101 | regulation of T cell tolerance induction (GO:0002664) | 2.62540176 |
| 102 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.60853712 |
| 103 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.60512388 |
| 104 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.60379333 |
| 105 | response to laminar fluid shear stress (GO:0034616) | 2.60282688 |
| 106 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.59997542 |
| 107 | positive thymic T cell selection (GO:0045059) | 2.58954963 |
| 108 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.58417305 |
| 109 | defense response to protozoan (GO:0042832) | 2.58402669 |
| 110 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.56584084 |
| 111 | positive T cell selection (GO:0043368) | 2.55338110 |
| 112 | natural killer cell differentiation (GO:0001779) | 2.55169191 |
| 113 | B cell homeostasis (GO:0001782) | 2.54868818 |
| 114 | positive regulation of Rap GTPase activity (GO:0032854) | 2.53477589 |
| 115 | synaptic transmission, glutamatergic (GO:0035249) | 2.52923566 |
| 116 | glutamate secretion (GO:0014047) | 2.52678431 |
| 117 | vocalization behavior (GO:0071625) | 2.52605851 |
| 118 | peptidyl-lysine trimethylation (GO:0018023) | 2.52306713 |
| 119 | regulation of interferon-alpha production (GO:0032647) | 2.51530601 |
| 120 | respiratory burst (GO:0045730) | 2.51210487 |
| 121 | histone methylation (GO:0016571) | 2.50960788 |
| 122 | proline transport (GO:0015824) | 2.48179012 |
| 123 | T cell selection (GO:0045058) | 2.47109554 |
| 124 | long-term memory (GO:0007616) | 2.44431003 |
| 125 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.43810482 |
| 126 | regulation of Rap GTPase activity (GO:0032317) | 2.43202844 |
| 127 | regulation of synaptic vesicle transport (GO:1902803) | 2.42274087 |
| 128 | NIK/NF-kappaB signaling (GO:0038061) | 2.42111845 |
| 129 | B cell receptor signaling pathway (GO:0050853) | 2.40432143 |
| 130 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.40246865 |
| 131 | thymic T cell selection (GO:0045061) | 2.40055697 |
| 132 | interferon-gamma production (GO:0032609) | 2.39207715 |
| 133 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.38462676 |
| 134 | protein localization to synapse (GO:0035418) | 2.37974110 |
| 135 | sodium ion export (GO:0071436) | 2.37076633 |
| 136 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.36647672 |
| 137 | histone H4 acetylation (GO:0043967) | 2.34811322 |
| 138 | peptidyl-arginine methylation (GO:0018216) | 2.34516030 |
| 139 | peptidyl-arginine N-methylation (GO:0035246) | 2.34516030 |
| 140 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.34274542 |
| 141 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.27615830 |
| 142 | positive regulation of granulocyte differentiation (GO:0030854) | 2.27607875 |
| 143 | layer formation in cerebral cortex (GO:0021819) | 2.27269724 |
| 144 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.25474522 |
| 145 | neuronal action potential propagation (GO:0019227) | 2.25277672 |
| 146 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.25034986 |
| 147 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.24087019 |
| 148 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.22867549 |
| 149 | histone deubiquitination (GO:0016578) | 2.22752247 |
| 150 | tachykinin receptor signaling pathway (GO:0007217) | 2.22483389 |
| 151 | regulation of ARF GTPase activity (GO:0032312) | 2.21756705 |
| 152 | nuclear pore complex assembly (GO:0051292) | 2.21159004 |
| 153 | glutamate receptor signaling pathway (GO:0007215) | 2.20686861 |
| 154 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.19936906 |
| 155 | neuron cell-cell adhesion (GO:0007158) | 2.17712904 |
| 156 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.17414492 |
| 157 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.16216956 |
| 158 | neuron-neuron synaptic transmission (GO:0007270) | 2.15044923 |
| 159 | modulation by virus of host process (GO:0019054) | 2.13730812 |
| 160 | neurotransmitter secretion (GO:0007269) | 2.13024622 |
| 161 | membrane depolarization during action potential (GO:0086010) | 2.12166506 |
| 162 | neuromuscular process controlling balance (GO:0050885) | 2.11216671 |
| 163 | positive regulation of synapse maturation (GO:0090129) | 2.09713397 |
| 164 | macrophage activation involved in immune response (GO:0002281) | 2.08474109 |
| 165 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.08306492 |
| 166 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.07038462 |
| 167 | regulation of gamma-delta T cell activation (GO:0046643) | 2.06706884 |
| 168 | positive regulation of membrane potential (GO:0045838) | 2.06486123 |
| 169 | regulation of postsynaptic membrane potential (GO:0060078) | 2.06428890 |
| 170 | peptidyl-threonine phosphorylation (GO:0018107) | 2.06288046 |
| 171 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.06281412 |
| 172 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.05936471 |
| 173 | positive regulation of RNA splicing (GO:0033120) | 2.04305189 |
| 174 | regulation of chromatin binding (GO:0035561) | 2.04177560 |
| 175 | pore complex assembly (GO:0046931) | 2.02433144 |
| 176 | exploration behavior (GO:0035640) | 2.01865787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.17278706 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.19251890 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.08532772 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.86109286 |
| 5 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.83164742 |
| 6 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.69342970 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.68834155 |
| 8 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.61787904 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.54844150 |
| 10 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.42208875 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.36582479 |
| 12 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.13917234 |
| 13 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.12678047 |
| 14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.08012879 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.96953240 |
| 16 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.94198315 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.92754180 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.92521364 |
| 19 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.92252885 |
| 20 | P68_20966046_ChIP-Seq_HELA_Human | 1.90610902 |
| 21 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.89206352 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.86632222 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.85088428 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.84751378 |
| 25 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.84385408 |
| 26 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.79220642 |
| 27 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.76696115 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.72167934 |
| 29 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.69687566 |
| 30 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.68378171 |
| 31 | KDM2B_26808549_Chip-Seq_K562_Human | 1.67162945 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.64220770 |
| 33 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.62230365 |
| 34 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60687921 |
| 35 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.58896999 |
| 36 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.57477493 |
| 37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.57248913 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55379485 |
| 39 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.55368909 |
| 40 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53806686 |
| 41 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53582224 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53463191 |
| 43 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.53269238 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.51233968 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49957275 |
| 46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49758752 |
| 47 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.49685828 |
| 48 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.49022639 |
| 49 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.47446410 |
| 50 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.47168676 |
| 51 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.47153708 |
| 52 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.47036623 |
| 53 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.46533813 |
| 54 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.44984698 |
| 55 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.43338995 |
| 56 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.42476808 |
| 57 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.41712749 |
| 58 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.40447702 |
| 59 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.40408836 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.39301180 |
| 61 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39100939 |
| 62 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38391360 |
| 63 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.38270612 |
| 64 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.38213661 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37932609 |
| 66 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.37868632 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36837147 |
| 68 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.36698880 |
| 69 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.36151137 |
| 70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.36047236 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35524593 |
| 72 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.35041784 |
| 73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.32858745 |
| 74 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.32577536 |
| 75 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.26851307 |
| 76 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.25911000 |
| 77 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.25469217 |
| 78 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.25073920 |
| 79 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.24912964 |
| 80 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.24756526 |
| 81 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.23897145 |
| 82 | MAF_26560356_Chip-Seq_TH1_Human | 1.23477540 |
| 83 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.23146880 |
| 84 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22108087 |
| 85 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20589139 |
| 86 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.20015082 |
| 87 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.19115861 |
| 88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18862310 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.18703480 |
| 90 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.18492229 |
| 91 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18467868 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17216634 |
| 93 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.16627445 |
| 94 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.16627445 |
| 95 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.16627445 |
| 96 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.16099444 |
| 97 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.15498880 |
| 98 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.15155779 |
| 99 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.13512153 |
| 100 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13502164 |
| 101 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12232864 |
| 102 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12118132 |
| 103 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.11884314 |
| 104 | MYB_26560356_Chip-Seq_TH2_Human | 1.11671323 |
| 105 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.11529431 |
| 106 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11033235 |
| 107 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.08850627 |
| 108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08534900 |
| 109 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07909186 |
| 110 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07751018 |
| 111 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.07557226 |
| 112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06901885 |
| 113 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.06821436 |
| 114 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.06634514 |
| 115 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06210971 |
| 116 | MYB_26560356_Chip-Seq_TH1_Human | 1.05453901 |
| 117 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05075979 |
| 118 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05072498 |
| 119 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04921870 |
| 120 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04906531 |
| 121 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04428390 |
| 122 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.04249143 |
| 123 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03157568 |
| 124 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02598736 |
| 125 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02434644 |
| 126 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.99710759 |
| 127 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96025664 |
| 128 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.95583369 |
| 129 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93720748 |
| 130 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.93205499 |
| 131 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93051069 |
| 132 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92635310 |
| 133 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91383081 |
| 134 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.90895245 |
| 135 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90894126 |
| 136 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.90004155 |
| 137 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.89406183 |
| 138 | MAF_26560356_Chip-Seq_TH2_Human | 0.88880908 |
| 139 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.88582465 |
| 140 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.87892992 |
| 141 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.87126642 |
| 142 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.86374185 |
| 143 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.86131688 |
| 144 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.85986119 |
| 145 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85564909 |
| 146 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.84832835 |
| 147 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.84560337 |
| 148 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.84235682 |
| 149 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.83621993 |
| 150 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.83077866 |
| 151 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.82925193 |
| 152 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.80812996 |
| 153 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.79824582 |
| 154 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.79804976 |
| 155 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.79096886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.17902942 |
| 2 | MP0003436_decreased_susceptibility_to | 3.56115238 |
| 3 | MP0003787_abnormal_imprinting | 3.54239939 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.41359331 |
| 5 | MP0008057_abnormal_DNA_replication | 2.55747808 |
| 6 | MP0005451_abnormal_body_composition | 2.47249523 |
| 7 | MP0004270_analgesia | 2.45642202 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 2.45041336 |
| 9 | MP0003880_abnormal_central_pattern | 2.38455988 |
| 10 | MP0005409_darkened_coat_color | 2.33318363 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.29179124 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.18599434 |
| 13 | MP0002419_abnormal_innate_immunity | 2.17580117 |
| 14 | MP0005025_abnormal_response_to | 2.16069199 |
| 15 | MP0001986_abnormal_taste_sensitivity | 2.13527155 |
| 16 | MP0008260_abnormal_autophagy | 2.08032753 |
| 17 | MP0008877_abnormal_DNA_methylation | 2.01705737 |
| 18 | MP0005310_abnormal_salivary_gland | 1.93615355 |
| 19 | MP0004381_abnormal_hair_follicle | 1.91451976 |
| 20 | MP0002063_abnormal_learning/memory/cond | 1.89956987 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 1.89635714 |
| 22 | MP0003300_gastrointestinal_ulcer | 1.89332336 |
| 23 | MP0003724_increased_susceptibility_to | 1.87440962 |
| 24 | MP0002653_abnormal_ependyma_morphology | 1.86355961 |
| 25 | MP0004947_skin_inflammation | 1.85226434 |
| 26 | MP0004510_myositis | 1.78212889 |
| 27 | MP0005171_absent_coat_pigmentation | 1.77191407 |
| 28 | MP0003111_abnormal_nucleus_morphology | 1.71068921 |
| 29 | MP0002064_seizures | 1.70940150 |
| 30 | MP0009046_muscle_twitch | 1.69999734 |
| 31 | MP0009745_abnormal_behavioral_response | 1.68623790 |
| 32 | MP0001835_abnormal_antigen_presentation | 1.66986497 |
| 33 | MP0003453_abnormal_keratinocyte_physiol | 1.66010394 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.61885271 |
| 35 | MP0003121_genomic_imprinting | 1.60315132 |
| 36 | MP0002572_abnormal_emotion/affect_behav | 1.56727693 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.53123313 |
| 38 | MP0005671_abnormal_response_to | 1.51808574 |
| 39 | MP0010094_abnormal_chromosome_stability | 1.51315611 |
| 40 | MP0001486_abnormal_startle_reflex | 1.51154778 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.49479336 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.48990463 |
| 43 | MP0004185_abnormal_adipocyte_glucose | 1.44119986 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.43638538 |
| 45 | MP0005394_taste/olfaction_phenotype | 1.42970128 |
| 46 | MP0005499_abnormal_olfactory_system | 1.42970128 |
| 47 | MP0001968_abnormal_touch/_nociception | 1.42805809 |
| 48 | MP0009785_altered_susceptibility_to | 1.42271035 |
| 49 | MP0002734_abnormal_mechanical_nocicepti | 1.41169987 |
| 50 | MP0008961_abnormal_basal_metabolism | 1.39397982 |
| 51 | MP0000858_altered_metastatic_potential | 1.37470204 |
| 52 | MP0001800_abnormal_humoral_immune | 1.36454079 |
| 53 | MP0003763_abnormal_thymus_physiology | 1.35928734 |
| 54 | MP0008569_lethality_at_weaning | 1.35122615 |
| 55 | MP0002822_catalepsy | 1.34911659 |
| 56 | MP0003077_abnormal_cell_cycle | 1.33797536 |
| 57 | MP0003303_peritoneal_inflammation | 1.30599851 |
| 58 | MP0001348_abnormal_lacrimal_gland | 1.29610747 |
| 59 | MP0009840_abnormal_foam_cell | 1.29299478 |
| 60 | MP0002272_abnormal_nervous_system | 1.28847345 |
| 61 | MP0006292_abnormal_olfactory_placode | 1.28609334 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.28192442 |
| 63 | MP0003091_abnormal_cell_migration | 1.27021734 |
| 64 | MP0002398_abnormal_bone_marrow | 1.26834892 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.25186135 |
| 66 | MP0000703_abnormal_thymus_morphology | 1.24312086 |
| 67 | MP0005083_abnormal_biliary_tract | 1.21982435 |
| 68 | MP0004811_abnormal_neuron_physiology | 1.21923729 |
| 69 | MP0000685_abnormal_immune_system | 1.21776789 |
| 70 | MP0004808_abnormal_hematopoietic_stem | 1.20114262 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 1.18647467 |
| 72 | MP0002132_abnormal_respiratory_system | 1.18554763 |
| 73 | MP0001845_abnormal_inflammatory_respons | 1.18322343 |
| 74 | MP0002184_abnormal_innervation | 1.18038953 |
| 75 | MP0002735_abnormal_chemical_nociception | 1.17301955 |
| 76 | MP0003879_abnormal_hair_cell | 1.16739067 |
| 77 | MP0000778_abnormal_nervous_system | 1.16129476 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.14445402 |
| 79 | MP0006082_CNS_inflammation | 1.11900686 |
| 80 | MP0000955_abnormal_spinal_cord | 1.11188864 |
| 81 | MP0003191_abnormal_cellular_cholesterol | 1.10543169 |
| 82 | MP0002067_abnormal_sensory_capabilities | 1.09676410 |
| 83 | MP0000015_abnormal_ear_pigmentation | 1.09552983 |
| 84 | MP0001970_abnormal_pain_threshold | 1.08577633 |
| 85 | MP0002736_abnormal_nociception_after | 1.08444719 |
| 86 | MP0003123_paternal_imprinting | 1.07806173 |
| 87 | MP0001501_abnormal_sleep_pattern | 1.07635944 |
| 88 | MP0000490_abnormal_crypts_of | 1.05977526 |
| 89 | MP0002733_abnormal_thermal_nociception | 1.04474667 |
| 90 | MP0002254_reproductive_system_inflammat | 1.02868360 |
| 91 | MP0002452_abnormal_antigen_presenting | 1.02576785 |
| 92 | MP0008469_abnormal_protein_level | 1.01178721 |
| 93 | MP0009278_abnormal_bone_marrow | 1.00786817 |
| 94 | MP0002420_abnormal_adaptive_immunity | 1.00482123 |
| 95 | MP0002933_joint_inflammation | 0.99702269 |
| 96 | MP0001819_abnormal_immune_cell | 0.99348772 |
| 97 | MP0000716_abnormal_immune_system | 0.98743238 |
| 98 | MP0005387_immune_system_phenotype | 0.98728800 |
| 99 | MP0001790_abnormal_immune_system | 0.98728800 |
| 100 | MP0001440_abnormal_grooming_behavior | 0.98268011 |
| 101 | MP0005666_abnormal_adipose_tissue | 0.97778302 |
| 102 | MP0005000_abnormal_immune_tolerance | 0.97496639 |
| 103 | MP0008058_abnormal_DNA_repair | 0.96859023 |
| 104 | MP0004924_abnormal_behavior | 0.96856778 |
| 105 | MP0005386_behavior/neurological_phenoty | 0.96856778 |
| 106 | MP0000678_abnormal_parathyroid_gland | 0.96187188 |
| 107 | MP0002722_abnormal_immune_system | 0.95821876 |
| 108 | MP0000350_abnormal_cell_proliferation | 0.95265196 |
| 109 | MP0002723_abnormal_immune_serum | 0.95206189 |
| 110 | MP0005174_abnormal_tail_pigmentation | 0.94478283 |
| 111 | MP0005076_abnormal_cell_differentiation | 0.94460813 |
| 112 | MP0004264_abnormal_extraembryonic_tissu | 0.94435488 |
| 113 | MP0002019_abnormal_tumor_incidence | 0.94265201 |
| 114 | MP0000689_abnormal_spleen_morphology | 0.92769008 |
| 115 | MP0003693_abnormal_embryo_hatching | 0.92217518 |
| 116 | MP0003828_pulmonary_edema | 0.92070575 |
| 117 | MP0004858_abnormal_nervous_system | 0.91419202 |
| 118 | MP0002166_altered_tumor_susceptibility | 0.89708065 |
| 119 | MP0003448_altered_tumor_morphology | 0.89405977 |
| 120 | MP0008007_abnormal_cellular_replicative | 0.87168166 |
| 121 | MP0004885_abnormal_endolymph | 0.86961250 |
| 122 | MP0005646_abnormal_pituitary_gland | 0.86699842 |
| 123 | MP0002882_abnormal_neuron_morphology | 0.86521135 |
| 124 | MP0009333_abnormal_splenocyte_physiolog | 0.86425559 |
| 125 | MP0002163_abnormal_gland_morphology | 0.85660958 |
| 126 | MP0003136_yellow_coat_color | 0.84584832 |
| 127 | MP0002557_abnormal_social/conspecific_i | 0.84386401 |
| 128 | MP0003866_abnormal_defecation | 0.83896515 |
| 129 | MP0001851_eye_inflammation | 0.83531891 |
| 130 | MP0001502_abnormal_circadian_rhythm | 0.83303511 |
| 131 | MP0002152_abnormal_brain_morphology | 0.83200277 |
| 132 | MP0010307_abnormal_tumor_latency | 0.83156504 |
| 133 | MP0005375_adipose_tissue_phenotype | 0.82204771 |
| 134 | MP0009931_abnormal_skin_appearance | 0.82025440 |
| 135 | MP0003045_fibrosis | 0.81977554 |
| 136 | MP0004130_abnormal_muscle_cell | 0.81417142 |
| 137 | MP0005397_hematopoietic_system_phenotyp | 0.79006623 |
| 138 | MP0001545_abnormal_hematopoietic_system | 0.79006623 |
| 139 | MP0002405_respiratory_system_inflammati | 0.78295851 |
| 140 | MP0003861_abnormal_nervous_system | 0.77333387 |
| 141 | MP0002429_abnormal_blood_cell | 0.77252770 |
| 142 | MP0002066_abnormal_motor_capabilities/c | 0.77040583 |
| 143 | MP0002909_abnormal_adrenal_gland | 0.75927763 |
| 144 | MP0000003_abnormal_adipose_tissue | 0.75697633 |
| 145 | MP0001853_heart_inflammation | 0.75251094 |
| 146 | MP0001188_hyperpigmentation | 0.75021972 |
| 147 | MP0000313_abnormal_cell_death | 0.72842289 |
| 148 | MP0005645_abnormal_hypothalamus_physiol | 0.71853465 |
| 149 | MP0001873_stomach_inflammation | 0.69625849 |
| 150 | MP0001849_ear_inflammation | 0.69049038 |
| 151 | MP0005621_abnormal_cell_physiology | 0.68273355 |
| 152 | MP0003329_amyloid_beta_deposits | 0.68199101 |
| 153 | MP0002009_preneoplasia | 0.67756626 |
| 154 | MP0005501_abnormal_skin_physiology | 0.67323810 |
| 155 | MP0008874_decreased_physiological_sensi | 0.66703151 |
| 156 | MP0003690_abnormal_glial_cell | 0.64223939 |
| 157 | MP0003566_abnormal_cell_adhesion | 0.61700394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.31171060 |
| 2 | Abnormality of the fingertips (HP:0001211) | 3.53806364 |
| 3 | Focal motor seizures (HP:0011153) | 3.43768704 |
| 4 | Febrile seizures (HP:0002373) | 3.43185899 |
| 5 | Thin bony cortex (HP:0002753) | 3.38966911 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.34957130 |
| 7 | Gastrointestinal infarctions (HP:0005244) | 3.27016213 |
| 8 | Hemorrhage of the eye (HP:0011885) | 3.15536096 |
| 9 | Pustule (HP:0200039) | 3.07041123 |
| 10 | Focal seizures (HP:0007359) | 3.02865130 |
| 11 | Urethral obstruction (HP:0000796) | 2.95874221 |
| 12 | Cellulitis (HP:0100658) | 2.90049180 |
| 13 | Visual hallucinations (HP:0002367) | 2.77716726 |
| 14 | Ependymoma (HP:0002888) | 2.73944602 |
| 15 | Gastrointestinal inflammation (HP:0004386) | 2.73183041 |
| 16 | Epileptic encephalopathy (HP:0200134) | 2.73144101 |
| 17 | Ulnar bowing (HP:0003031) | 2.72497999 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 2.72240075 |
| 19 | Obstructive lung disease (HP:0006536) | 2.72240075 |
| 20 | Meningitis (HP:0001287) | 2.70802537 |
| 21 | Testicular atrophy (HP:0000029) | 2.69778575 |
| 22 | Increased IgE level (HP:0003212) | 2.68472504 |
| 23 | Atonic seizures (HP:0010819) | 2.65142888 |
| 24 | Poikiloderma (HP:0001029) | 2.61730607 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 2.56198622 |
| 26 | Inflammation of the large intestine (HP:0002037) | 2.53119232 |
| 27 | Recurrent skin infections (HP:0001581) | 2.52359925 |
| 28 | Basal cell carcinoma (HP:0002671) | 2.48899661 |
| 29 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.48477783 |
| 30 | Intestinal fistula (HP:0100819) | 2.43095867 |
| 31 | Metaphyseal cupping (HP:0003021) | 2.39250539 |
| 32 | Abnormality of the lower motor neuron (HP:0002366) | 2.38831425 |
| 33 | Turricephaly (HP:0000262) | 2.38674634 |
| 34 | Vasculitis (HP:0002633) | 2.36817552 |
| 35 | Myokymia (HP:0002411) | 2.36781591 |
| 36 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.35630826 |
| 37 | Chromsome breakage (HP:0040012) | 2.35095813 |
| 38 | Abnormality of the astrocytes (HP:0100707) | 2.35078299 |
| 39 | Astrocytoma (HP:0009592) | 2.35078299 |
| 40 | Gastrointestinal stroma tumor (HP:0100723) | 2.34315105 |
| 41 | Joint hemorrhage (HP:0005261) | 2.33776645 |
| 42 | Pointed chin (HP:0000307) | 2.33730506 |
| 43 | Hyperacusis (HP:0010780) | 2.30573288 |
| 44 | Slow saccadic eye movements (HP:0000514) | 2.29571032 |
| 45 | Epistaxis (HP:0000421) | 2.29110429 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 2.28550671 |
| 47 | Optic neuritis (HP:0100653) | 2.28550671 |
| 48 | Emphysema (HP:0002097) | 2.27981917 |
| 49 | Gingivitis (HP:0000230) | 2.24553217 |
| 50 | Vaginal fistula (HP:0004320) | 2.22981341 |
| 51 | Impaired smooth pursuit (HP:0007772) | 2.22745242 |
| 52 | Prolonged bleeding time (HP:0003010) | 2.21592258 |
| 53 | Abnormality of the labia minora (HP:0012880) | 2.19158257 |
| 54 | Spontaneous hematomas (HP:0007420) | 2.16090887 |
| 55 | Hypochromic anemia (HP:0001931) | 2.13013017 |
| 56 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.10124197 |
| 57 | Rectovaginal fistula (HP:0000143) | 2.09898491 |
| 58 | Rectal fistula (HP:0100590) | 2.09898491 |
| 59 | Dysostosis multiplex (HP:0000943) | 2.09853638 |
| 60 | Anal stenosis (HP:0002025) | 2.09337236 |
| 61 | Orchitis (HP:0100796) | 2.09163752 |
| 62 | Heterotopia (HP:0002282) | 2.08735584 |
| 63 | Hypertensive crisis (HP:0100735) | 2.07725852 |
| 64 | Panhypogammaglobulinemia (HP:0003139) | 2.07659336 |
| 65 | Chest pain (HP:0100749) | 2.07205123 |
| 66 | Myositis (HP:0100614) | 2.07164545 |
| 67 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.06938077 |
| 68 | Easy fatigability (HP:0003388) | 2.06197321 |
| 69 | Broad face (HP:0000283) | 2.05968654 |
| 70 | Obstructive sleep apnea (HP:0002870) | 2.04912836 |
| 71 | Absence seizures (HP:0002121) | 2.02654658 |
| 72 | Anteriorly placed anus (HP:0001545) | 2.02248278 |
| 73 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.00878731 |
| 74 | Neoplasm of the oral cavity (HP:0100649) | 2.00673863 |
| 75 | Acute lymphatic leukemia (HP:0006721) | 1.99418825 |
| 76 | Progressive cerebellar ataxia (HP:0002073) | 1.99211345 |
| 77 | Thin ribs (HP:0000883) | 1.97779388 |
| 78 | Osteomyelitis (HP:0002754) | 1.97758309 |
| 79 | Birth length less than 3rd percentile (HP:0003561) | 1.96245595 |
| 80 | Supranuclear gaze palsy (HP:0000605) | 1.95817442 |
| 81 | Volvulus (HP:0002580) | 1.94898756 |
| 82 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94832888 |
| 83 | Mucopolysacchariduria (HP:0008155) | 1.94832888 |
| 84 | Squamous cell carcinoma (HP:0002860) | 1.94272577 |
| 85 | Dialeptic seizures (HP:0011146) | 1.93892706 |
| 86 | Neuronal loss in central nervous system (HP:0002529) | 1.93801521 |
| 87 | Rib fusion (HP:0000902) | 1.93756793 |
| 88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93694448 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93694448 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93694448 |
| 91 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.93052216 |
| 92 | Recurrent cutaneous fungal infections (HP:0011370) | 1.93052216 |
| 93 | Recurrent fungal infections (HP:0002841) | 1.91693145 |
| 94 | Encephalitis (HP:0002383) | 1.91006547 |
| 95 | Genetic anticipation (HP:0003743) | 1.89532517 |
| 96 | Prominent nose (HP:0000448) | 1.88013459 |
| 97 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.86923162 |
| 98 | Inappropriate behavior (HP:0000719) | 1.86826354 |
| 99 | Annular pancreas (HP:0001734) | 1.85109387 |
| 100 | Trigonocephaly (HP:0000243) | 1.84717308 |
| 101 | Cheilitis (HP:0100825) | 1.84551479 |
| 102 | Long eyelashes (HP:0000527) | 1.84370942 |
| 103 | Agammaglobulinemia (HP:0004432) | 1.84220183 |
| 104 | Increased serum ferritin (HP:0003281) | 1.83899541 |
| 105 | Protruding tongue (HP:0010808) | 1.83840005 |
| 106 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.83482405 |
| 107 | Glioma (HP:0009733) | 1.83062305 |
| 108 | Colitis (HP:0002583) | 1.83029533 |
| 109 | Agnosia (HP:0010524) | 1.83015889 |
| 110 | Myopathic facies (HP:0002058) | 1.82818699 |
| 111 | Truncal ataxia (HP:0002078) | 1.81897439 |
| 112 | Lip pit (HP:0100267) | 1.81865702 |
| 113 | Ectopic kidney (HP:0000086) | 1.81537792 |
| 114 | Urticaria (HP:0001025) | 1.80850067 |
| 115 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.79856542 |
| 116 | Arterial thrombosis (HP:0004420) | 1.79780233 |
| 117 | Myelodysplasia (HP:0002863) | 1.79692288 |
| 118 | Restrictive lung disease (HP:0002091) | 1.78764368 |
| 119 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.78155357 |
| 120 | Abnormality of the thoracic spine (HP:0100711) | 1.77477164 |
| 121 | Gaze-evoked nystagmus (HP:0000640) | 1.76662320 |
| 122 | Ankle clonus (HP:0011448) | 1.76038540 |
| 123 | Capillary hemangiomas (HP:0005306) | 1.75585476 |
| 124 | Lymphopenia (HP:0001888) | 1.75522284 |
| 125 | Abnormality of glycolipid metabolism (HP:0010969) | 1.75121324 |
| 126 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.75121324 |
| 127 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.75121324 |
| 128 | Patellar aplasia (HP:0006443) | 1.73878814 |
| 129 | Insomnia (HP:0100785) | 1.72872624 |
| 130 | Progressive external ophthalmoplegia (HP:0000590) | 1.72111291 |
| 131 | Stomatitis (HP:0010280) | 1.71502973 |
| 132 | Joint stiffness (HP:0001387) | 1.71303103 |
| 133 | Increased cerebral lipofuscin (HP:0011813) | 1.70773190 |
| 134 | Hypertriglyceridemia (HP:0002155) | 1.70335391 |
| 135 | Recurrent viral infections (HP:0004429) | 1.70202064 |
| 136 | Disproportionate tall stature (HP:0001519) | 1.70073958 |
| 137 | Postural instability (HP:0002172) | 1.69914009 |
| 138 | Delayed epiphyseal ossification (HP:0002663) | 1.69476482 |
| 139 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.69227990 |
| 140 | Pulmonary infiltrates (HP:0002113) | 1.67836559 |
| 141 | Papilloma (HP:0012740) | 1.67570139 |
| 142 | Verrucae (HP:0200043) | 1.67570139 |
| 143 | Tented upper lip vermilion (HP:0010804) | 1.66639105 |
| 144 | Anorexia (HP:0002039) | 1.66167445 |
| 145 | Akinesia (HP:0002304) | 1.65667032 |
| 146 | Medulloblastoma (HP:0002885) | 1.65546830 |
| 147 | Stereotypic behavior (HP:0000733) | 1.65404508 |
| 148 | Fatigue (HP:0012378) | 1.65379410 |
| 149 | Recurrent abscess formation (HP:0002722) | 1.63945898 |
| 150 | Abnormality of the common coagulation pathway (HP:0010990) | 1.63802504 |
| 151 | Polycythemia (HP:0001901) | 1.63529839 |
| 152 | Long palpebral fissure (HP:0000637) | 1.63048885 |
| 153 | Skin tags (HP:0010609) | 1.62581285 |
| 154 | Papillary thyroid carcinoma (HP:0002895) | 1.62524619 |
| 155 | Lower limb amyotrophy (HP:0007210) | 1.62499829 |
| 156 | Abnormal hair whorl (HP:0010721) | 1.62005467 |
| 157 | Elfin facies (HP:0004428) | 1.61434827 |
| 158 | Failure to thrive in infancy (HP:0001531) | 1.61124231 |
| 159 | Poor eye contact (HP:0000817) | 1.60837840 |
| 160 | Amyotrophic lateral sclerosis (HP:0007354) | 1.60672870 |
| 161 | Dysmetric saccades (HP:0000641) | 1.60599853 |
| 162 | Abnormality of the carotid arteries (HP:0005344) | 1.60049124 |
| 163 | Mask-like facies (HP:0000298) | 1.59693876 |
| 164 | Spinal canal stenosis (HP:0003416) | 1.59184726 |
| 165 | Recurrent bacterial skin infections (HP:0005406) | 1.59050582 |
| 166 | Neoplasm of the heart (HP:0100544) | 1.58972432 |
| 167 | Hemiplegia (HP:0002301) | 1.57392418 |
| 168 | Shawl scrotum (HP:0000049) | 1.57331498 |
| 169 | Diplopia (HP:0000651) | 1.56965635 |
| 170 | Abnormality of binocular vision (HP:0011514) | 1.56965635 |
| 171 | Facial hemangioma (HP:0000329) | 1.56749122 |
| 172 | Broad-based gait (HP:0002136) | 1.56491471 |
| 173 | Clubbing of toes (HP:0100760) | 1.56332132 |
| 174 | Vertebral arch anomaly (HP:0008438) | 1.56077114 |
| 175 | Upper motor neuron abnormality (HP:0002127) | 1.55601162 |
| 176 | Meckel diverticulum (HP:0002245) | 1.55012999 |
| 177 | Cafe-au-lait spot (HP:0000957) | 1.55010838 |
| 178 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.54572899 |
| 179 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.54368105 |
| 180 | Increased nuchal translucency (HP:0010880) | 1.54321925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 4.18537703 |
| 2 | MAP3K9 | 3.60043397 |
| 3 | TRIB3 | 3.36277041 |
| 4 | SIK2 | 3.05109109 |
| 5 | ERN1 | 3.00438389 |
| 6 | NTRK3 | 2.63566527 |
| 7 | BRD4 | 2.61054058 |
| 8 | MAP2K3 | 2.58843970 |
| 9 | SMG1 | 2.43156492 |
| 10 | BLK | 2.37690770 |
| 11 | SIK1 | 2.22311840 |
| 12 | MAP3K13 | 2.13204453 |
| 13 | MAP4K1 | 2.10454118 |
| 14 | RIPK4 | 2.05641740 |
| 15 | KSR2 | 1.96440257 |
| 16 | DAPK2 | 1.84450849 |
| 17 | NTRK2 | 1.81764638 |
| 18 | PAK6 | 1.75962357 |
| 19 | FGFR4 | 1.75671048 |
| 20 | MAPK15 | 1.73567390 |
| 21 | EPHA4 | 1.70466584 |
| 22 | TAOK1 | 1.61523251 |
| 23 | ALK | 1.60489772 |
| 24 | CSK | 1.54937827 |
| 25 | IRAK4 | 1.54024104 |
| 26 | STK38 | 1.51633167 |
| 27 | SGK3 | 1.51348236 |
| 28 | KSR1 | 1.43901048 |
| 29 | GRK5 | 1.43028170 |
| 30 | SGK2 | 1.42317699 |
| 31 | EEF2K | 1.41621541 |
| 32 | TYRO3 | 1.39436115 |
| 33 | GRK6 | 1.34859313 |
| 34 | TBK1 | 1.34315493 |
| 35 | MAP3K10 | 1.33572481 |
| 36 | MAP3K4 | 1.33446443 |
| 37 | SIK3 | 1.33330902 |
| 38 | BMPR2 | 1.30556961 |
| 39 | FES | 1.30414310 |
| 40 | HIPK2 | 1.26572212 |
| 41 | MAPK7 | 1.25361061 |
| 42 | MAPK13 | 1.20142470 |
| 43 | BTK | 1.19682122 |
| 44 | PKN2 | 1.12262849 |
| 45 | CDK4 | 1.11400296 |
| 46 | DAPK1 | 1.11389728 |
| 47 | EPHB1 | 1.11308448 |
| 48 | MARK2 | 1.10100897 |
| 49 | TNK2 | 1.08613181 |
| 50 | RAF1 | 1.06866095 |
| 51 | CDC7 | 1.02763533 |
| 52 | IKBKE | 1.02138540 |
| 53 | PRKD3 | 1.00120139 |
| 54 | RIPK1 | 1.00044270 |
| 55 | MAP3K11 | 1.00004442 |
| 56 | PRPF4B | 0.98402646 |
| 57 | PDPK1 | 0.96494966 |
| 58 | TXK | 0.96451019 |
| 59 | MINK1 | 0.95848853 |
| 60 | RPS6KA2 | 0.93132745 |
| 61 | LATS2 | 0.92937150 |
| 62 | TAOK2 | 0.92819998 |
| 63 | IKBKB | 0.92623926 |
| 64 | CAMKK1 | 0.92346850 |
| 65 | IRAK3 | 0.92338742 |
| 66 | MAP3K3 | 0.91744807 |
| 67 | MAP3K6 | 0.89569527 |
| 68 | PTK6 | 0.88837542 |
| 69 | SYK | 0.87202835 |
| 70 | CAMK1G | 0.87138012 |
| 71 | MARK1 | 0.86927392 |
| 72 | BMX | 0.85239211 |
| 73 | HCK | 0.82955010 |
| 74 | MAPK11 | 0.82156228 |
| 75 | CAMK4 | 0.81928944 |
| 76 | MAP3K12 | 0.81429297 |
| 77 | MAP2K6 | 0.80444433 |
| 78 | IRAK2 | 0.79784280 |
| 79 | PRKCH | 0.79495062 |
| 80 | NEK2 | 0.78618702 |
| 81 | TESK2 | 0.78185445 |
| 82 | STK11 | 0.76358090 |
| 83 | MAP2K4 | 0.75983174 |
| 84 | WNK1 | 0.75628609 |
| 85 | DYRK1B | 0.74735305 |
| 86 | MAPK10 | 0.74720875 |
| 87 | FGR | 0.74610000 |
| 88 | DYRK1A | 0.74191451 |
| 89 | LYN | 0.74079118 |
| 90 | JAK2 | 0.73952515 |
| 91 | SGK494 | 0.73229312 |
| 92 | SGK223 | 0.73229312 |
| 93 | JAK1 | 0.72832835 |
| 94 | MAP2K7 | 0.72649485 |
| 95 | MAPK12 | 0.71056136 |
| 96 | MAP3K14 | 0.70982186 |
| 97 | CHUK | 0.70303018 |
| 98 | MATK | 0.70231748 |
| 99 | RPS6KC1 | 0.70134308 |
| 100 | RPS6KL1 | 0.70134308 |
| 101 | MAP3K7 | 0.69502051 |
| 102 | CHEK1 | 0.68058370 |
| 103 | CDC42BPA | 0.67956935 |
| 104 | CDK5 | 0.66355394 |
| 105 | CDK2 | 0.64836902 |
| 106 | CHEK2 | 0.64382282 |
| 107 | MARK3 | 0.64145256 |
| 108 | CDK6 | 0.63120153 |
| 109 | ITK | 0.63056159 |
| 110 | ATR | 0.62699296 |
| 111 | SGK1 | 0.62566786 |
| 112 | NME2 | 0.61815920 |
| 113 | CDK8 | 0.60824039 |
| 114 | ARAF | 0.60812476 |
| 115 | LCK | 0.60707915 |
| 116 | TYK2 | 0.60401449 |
| 117 | FGFR3 | 0.59847716 |
| 118 | NTRK1 | 0.56119217 |
| 119 | MTOR | 0.55850071 |
| 120 | GSK3B | 0.55306384 |
| 121 | KIT | 0.54791225 |
| 122 | TTK | 0.53932910 |
| 123 | RPS6KA6 | 0.52742042 |
| 124 | MAP3K1 | 0.52513731 |
| 125 | JAK3 | 0.51872170 |
| 126 | ICK | 0.50951293 |
| 127 | CAMK1D | 0.50642768 |
| 128 | MAPK14 | 0.49487792 |
| 129 | PDK1 | 0.49068168 |
| 130 | CCNB1 | 0.48898238 |
| 131 | CSF1R | 0.48822870 |
| 132 | STK10 | 0.48137504 |
| 133 | MAP3K8 | 0.47608953 |
| 134 | MAPK8 | 0.46385594 |
| 135 | RPS6KA3 | 0.46255039 |
| 136 | CDK9 | 0.46156286 |
| 137 | AKT3 | 0.45521926 |
| 138 | TTN | 0.45112809 |
| 139 | PRKD2 | 0.44186097 |
| 140 | NEK6 | 0.42278160 |
| 141 | RET | 0.42003814 |
| 142 | ZAP70 | 0.41352347 |
| 143 | CDK1 | 0.41170297 |
| 144 | CAMK1 | 0.40681543 |
| 145 | ATM | 0.40543488 |
| 146 | LRRK2 | 0.40434497 |
| 147 | CDK19 | 0.35762046 |
| 148 | MAP2K2 | 0.34434825 |
| 149 | RPS6KA1 | 0.34220685 |
| 150 | YES1 | 0.32833649 |
| 151 | PASK | 0.32522985 |
| 152 | PIM1 | 0.32402991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.48510443 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 1.94295179 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 1.80329516 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.73803906 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.66831504 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 1.61583633 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 1.57398629 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.56471114 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.54720382 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53328859 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 1.49420290 |
| 12 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.46889839 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 1.46541039 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.43103352 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.42595212 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.40994742 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38701110 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37590400 |
| 19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.36503709 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 1.30930924 |
| 21 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.26550787 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24577632 |
| 23 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.24054175 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21394675 |
| 25 | GABAergic synapse_Homo sapiens_hsa04727 | 1.20897577 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.20581000 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.20091390 |
| 28 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.19847586 |
| 29 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.18147637 |
| 30 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.17802575 |
| 31 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.17726511 |
| 32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.17697250 |
| 33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.17692355 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.17036233 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.16844604 |
| 36 | Hepatitis C_Homo sapiens_hsa05160 | 1.16636387 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.14265486 |
| 38 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.12803359 |
| 39 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12275885 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10733952 |
| 41 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10228571 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09686177 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.07023174 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.06613578 |
| 45 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.06177132 |
| 46 | Salivary secretion_Homo sapiens_hsa04970 | 1.05347601 |
| 47 | Glioma_Homo sapiens_hsa05214 | 1.04540264 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.04398233 |
| 49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03697115 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.03550440 |
| 51 | Long-term depression_Homo sapiens_hsa04730 | 1.03441329 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03113786 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02783133 |
| 54 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.01766141 |
| 55 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.01717762 |
| 56 | Bladder cancer_Homo sapiens_hsa05219 | 1.01627383 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.00700697 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 1.00567640 |
| 59 | Taste transduction_Homo sapiens_hsa04742 | 0.99650209 |
| 60 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99481794 |
| 61 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.98984118 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.97295000 |
| 63 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.96886975 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95415973 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.95319415 |
| 66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.95115494 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93484793 |
| 68 | Colorectal cancer_Homo sapiens_hsa05210 | 0.93443591 |
| 69 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92099457 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91215704 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.90963218 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90917932 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90156359 |
| 74 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.89600088 |
| 75 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.89556809 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89079988 |
| 77 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.88636259 |
| 78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87102772 |
| 79 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.86159432 |
| 80 | Malaria_Homo sapiens_hsa05144 | 0.84779999 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84289098 |
| 82 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.83996482 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83720500 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.82993090 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82630617 |
| 86 | Cocaine addiction_Homo sapiens_hsa05030 | 0.80331178 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.80132569 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.79756932 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78779814 |
| 90 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.78673958 |
| 91 | Leishmaniasis_Homo sapiens_hsa05140 | 0.77872238 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.77203600 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.75576217 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75366482 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74732643 |
| 96 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.74366974 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73499037 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73309436 |
| 99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72921942 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.71411611 |
| 101 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70652618 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.69719780 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.69316274 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68139261 |
| 105 | Tuberculosis_Homo sapiens_hsa05152 | 0.67474725 |
| 106 | Gap junction_Homo sapiens_hsa04540 | 0.67425861 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.66305871 |
| 108 | * Lysosome_Homo sapiens_hsa04142 | 0.65751734 |
| 109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65066328 |
| 110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64954658 |
| 111 | Base excision repair_Homo sapiens_hsa03410 | 0.64946995 |
| 112 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64791261 |
| 113 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64441303 |
| 114 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64103006 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63649403 |
| 116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63458264 |
| 117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.63385564 |
| 118 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63285109 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63104544 |
| 120 | Pertussis_Homo sapiens_hsa05133 | 0.62975385 |
| 121 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.62826873 |
| 122 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62265296 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60754580 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60318934 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60244091 |
| 126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59848572 |
| 127 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.59744422 |
| 128 | Cell cycle_Homo sapiens_hsa04110 | 0.59343399 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59231042 |
| 130 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59213539 |
| 131 | Shigellosis_Homo sapiens_hsa05131 | 0.58374551 |
| 132 | Apoptosis_Homo sapiens_hsa04210 | 0.58054371 |
| 133 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57604722 |
| 134 | Measles_Homo sapiens_hsa05162 | 0.57115590 |
| 135 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56791685 |
| 136 | RNA transport_Homo sapiens_hsa03013 | 0.56705793 |
| 137 | Legionellosis_Homo sapiens_hsa05134 | 0.56661379 |
| 138 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.56040703 |
| 139 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55731939 |
| 140 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55311747 |
| 141 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.55282002 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | 0.48595512 |
| 143 | Salmonella infection_Homo sapiens_hsa05132 | 0.47780689 |
| 144 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47553459 |

